6.
Hu Z, Fang C, Li B, Zhang Z, Cao C, Cai M
. First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows. Nat Biomed Eng. 2019; 4(3):259-271.
DOI: 10.1038/s41551-019-0494-0.
View
7.
Zheng J, Liang X
. ASO Author Reflections: Laparoscopic Anatomic Portal Territory Hepatectomy: A Trend Toward a Personalized Liver Surgery. Ann Surg Oncol. 2020; 27(13):5181-5182.
DOI: 10.1245/s10434-020-08596-2.
View
8.
Yong C, Yin S, Sng Y, Chen C
. Prevent bile duct injury by indocyanine green guide fluorescent imaging during laparoscopic cholecystectomy in liver transplantation recipient. Hepatobiliary Surg Nutr. 2020; 9(6):817-819.
PMC: 7720052.
DOI: 10.21037/hbsn-20-342.
View
9.
Gunasekaran G, Bekki Y, Lourdusamy V, Schwartz M
. Surgical Treatments of Hepatobiliary Cancers. Hepatology. 2020; 73 Suppl 1:128-136.
DOI: 10.1002/hep.31325.
View
10.
van der Vorst J, Schaafsma B, Hutteman M, Verbeek F, Liefers G, Hartgrink H
. Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer. 2013; 119(18):3411-8.
PMC: 3775857.
DOI: 10.1002/cncr.28203.
View
11.
Levesque E, Saliba F, Benhamida S, Ichai P, Azoulay D, Adam R
. Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation. Liver Transpl. 2009; 15(10):1358-64.
DOI: 10.1002/lt.21805.
View
12.
Xu F, Jin T, Zhu Y, Dai C
. Immune checkpoint therapy in liver cancer. J Exp Clin Cancer Res. 2018; 37(1):110.
PMC: 5975687.
DOI: 10.1186/s13046-018-0777-4.
View
13.
Harris W, Wong K, Saha S, El Dika I, Abou-Alfa G
. Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers. Semin Oncol. 2018; 45(3):116-123.
DOI: 10.1053/j.seminoncol.2018.03.002.
View
14.
Aoki T, Murakami M, Koizumi T, Matsuda K, Fujimori A, Kusano T
. Determination of the surgical margin in laparoscopic liver resections using infrared indocyanine green fluorescence. Langenbecks Arch Surg. 2018; 403(5):671-680.
DOI: 10.1007/s00423-018-1685-y.
View
15.
Moris D, Tsilimigras D, Kostakis I, Ntanasis-Stathopoulos I, Shah K, Felekouras E
. Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysis. Eur J Surg Oncol. 2018; 44(7):927-938.
DOI: 10.1016/j.ejso.2018.04.018.
View
16.
Benson R, Kues H
. Fluorescence properties of indocyanine green as related to angiography. Phys Med Biol. 1978; 23(1):159-63.
DOI: 10.1088/0031-9155/23/1/017.
View
17.
MacFadyen B
. Intraoperative cholangiography: past, present, and future. Surg Endosc. 2006; 20 Suppl 2:S436-40.
DOI: 10.1007/s00464-006-0053-0.
View
18.
Kudo M, Ueshima K, Ikeda M, Torimura T, Tanabe N, Aikata H
. Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial. Gut. 2019; 69(8):1492-1501.
PMC: 7398460.
DOI: 10.1136/gutjnl-2019-318934.
View
19.
Figueroa R, Golse N, Alvarez F, Ciacio O, Pittau G, Sa Cunha A
. Indocyanine green fluorescence imaging to evaluate graft perfusion during liver transplantation. HPB (Oxford). 2018; 21(4):387-392.
DOI: 10.1016/j.hpb.2018.09.001.
View
20.
Zhai S, Liang X, Mao Q, Liang Y, Xu J, Chen J
. A retrospective pilot study to examine the feasibility of real-time navigation for laparoscopic liver resections in intrahepatic cholangiocarcinoma using fusion indocyanine green fluorescence imaging. J Surg Oncol. 2020; 122(2):226-233.
DOI: 10.1002/jso.25940.
View